410 Medical had obtained their first FDA approval and was seeking multi-faceted health economics and market access support to communicate their value story and navigate their technology through hospital VAC approval processes. TTi developed both pediatric and adult population budgetary impact models for consideration by VACs. Associated white papers, conferences presentations, and peer-reviewed publications were also collaboratively produced from the findings of our models. Additionally, TTi engaged in multiple qualitative research initiatives with key clinical decision-makers to better understand how to position the client’s technology for success. These efforts were instrumental in supporting the client’s market adoption at facilities across the US.